| n | (%) | |
---|---|---|---|
Study design | RCT | 4 | (7) |
 | Longitudinal | 25 | (45) |
 | Cross-sectional | 27 | (48) |
Publication year | <1995 | 1 | (2) |
 | 1995-1999 | 6 | (11) |
 | 2000-2004 | 12 | (21) |
 | 2005-2009 | 26 | (46) |
 | 2010-2011 | 11 | (20) |
Primary outcome | Â | Â | Â |
  Clinical measure (for example, morbidity, mortality) | 2 | (4) | |
PRO (for example, HRQL, symptoms) | 40 | (7) | |
Undefined/both clinical & PRO | 14 | (25) | |
 | Studies using PROM (n) | PROM scales and single items (n) | |
PROM | QLQ-C30 | 34 | 15 |
QLQ-OES18 | 19 | 10 | |
SF36 | 12 | 8 | |
QLQ-OES24 | 8 | 11 | |
GIQLI | 3 | 5 | |
FACT-E | 3 | 5 | |
Adapted RSCL | 4 | 4/5a | |
QLQ-C36 | 2 | 18 | |
GERD-HRQL | 1 | 2 | |
DAUGS32 | 1 | 7 | |
LAGS | 1 | 3 | |
RSCL | 1 | 3 | |
Adapted RSCL | 1 | 5 | |
PNPC | 1 | 9 | |
WOCS | 1 | 1 | |
MOS SF20 | 1 | 6 | |
PAIS | 1 | 7 | |
POMS | 1 | 6 | |
HADS | 1 | 2 | |
EQOLb | 0 | 5 | |
QLQ-OG25b | 0 | 16 |